Taken together, these results indicate that inhibiting DNMT1 could suppress the EGFR/STAT3/PD-L1 pathway by inhibiting IGFBP2, thereby inhibiting the development of PCa. This evidence concerns the gene EGFR and posterior cortical atrophy.